Background and aims Non-alcoholic fatty liver disease is recognized not only as part of the metabolic syndrome but also as an independent predictor of cardiovascular disease. Methods In this study, NMR spectroscopy method, together with perfusion techniques, was used to detect subclinical brain vascular damage in subjects with NAFLD without overt atherosclerosis risk factors (i.e. hypertension, diabetes, hypercholesterolemia, obesity). Results The results suggest that subjects with histologically proven NAFLD have a reduced cerebral perfusion (CBFr) confined to limited brain areas, i.e., left semioval center and posterior cingulate cortex. No statistically significant differences in CBFr values were found, dividing the NAFLD cohort into subgroups, considering NAS score, presence/absence of NASH/fibrosis, and degree of steatosis. Conclusions Our data suggest that NAFLD per se may be involved in cerebral atherosclerotic disease. It will be interesting to draw longitudinal studies to determine whether these changes could evolve in more serious cerebral injury.

Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis / L. Airaghi, M. Rango, D. Maira, V. Barbieri, L. Valenti, R. Lombardi, P. Biondetti, S. Fargion, A.L. Fracanzani. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 268(2018 Jan), pp. 27-31. [10.1016/j.atherosclerosis.2017.11.012]

Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis

M. Rango;D. Maira;L. Valenti;R. Lombardi;S. Fargion;A.L. Fracanzani
2018

Abstract

Background and aims Non-alcoholic fatty liver disease is recognized not only as part of the metabolic syndrome but also as an independent predictor of cardiovascular disease. Methods In this study, NMR spectroscopy method, together with perfusion techniques, was used to detect subclinical brain vascular damage in subjects with NAFLD without overt atherosclerosis risk factors (i.e. hypertension, diabetes, hypercholesterolemia, obesity). Results The results suggest that subjects with histologically proven NAFLD have a reduced cerebral perfusion (CBFr) confined to limited brain areas, i.e., left semioval center and posterior cingulate cortex. No statistically significant differences in CBFr values were found, dividing the NAFLD cohort into subgroups, considering NAS score, presence/absence of NASH/fibrosis, and degree of steatosis. Conclusions Our data suggest that NAFLD per se may be involved in cerebral atherosclerotic disease. It will be interesting to draw longitudinal studies to determine whether these changes could evolve in more serious cerebral injury.
Atherosclerosis; Cerebral blood flow; Cerebrovascular disease; Magnetic resonance spectroscopy (MRS); Metabolic syndrome; Non-alcoholic fatty liver disease (NAFLD); Cardiology and Cardiovascular Medicine
Settore MED/09 - Medicina Interna
Early atherosclerosis in patients with steatosis and with chronic hepatitis C: role of visceral adiposity, procoagulant imbalance and endothelial dysfunction in vascular damage
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0021915017313825-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 263.33 kB
Formato Adobe PDF
263.33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/557538
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact